You are here

Dose–Conversion Ratio for Epoetin Alfa and Darbepoetin Alfa in Chemotherapy Patients with Anemia and Cancer

Antoine Gosselin, MA, R. Scott McKenzie, MD, Patrick Lefebvre, MA, Samir H. Mody, PharmD, MBA, Catherine Tak Piech, MBA, and Mei Sheng Duh, MPH, ScD
PDF version: 
The authors present the findings of a study that was designed to compare the effectiveness and equivalence of two erythropoietic agents based on a randomized, prospective clinical trial.